End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.92 CNY | -0.43% | -3.08% | -14.25% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 59% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company sustains low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.25% | 815M | - | ||
+6.11% | 105B | A- | ||
-4.67% | 63.83B | A- | ||
+73.81% | 45.28B | B | ||
+15.46% | 38.93B | B | ||
+5.24% | 33.06B | A- | ||
+11.42% | 20.21B | B- | ||
+13.74% | 16.94B | C+ | ||
+20.05% | 16.08B | B- | ||
+5.02% | 14.49B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603113 Stock
- Ratings Jinneng Science&Technology Co.,Ltd